Evidence map›Paper›PMID 39920658›Full record

ArticleBMC public health2025

Characterisation of cardiovascular disease (CVD) incidence and machine learning risk prediction in middle-aged and elderly populations: data from the China health and retirement longitudinal study (CHARLS).

Qing Huang, Zihao Jiang, Bo Shi, Jiaxu Meng, Li Shu, Fuyong Hu, Jing Mi

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Qing Huang *School of Public Health, Bengbu Medical University, No. 2600 Donghai Avenue, Bengbu, Anhui, 233030, China.
Zihao Jiang *School of Public Health, Bengbu Medical University, No. 2600 Donghai Avenue, Bengbu, Anhui, 233030, China.
Bo ShiSchool of Medical Imaging, Bengbu Medical University, No. 2600 Donghai Avenue, Bengbu, Anhui, 233030, China.
Jiaxu MengSchool of Medical Imaging, Bengbu Medical University, No. 2600 Donghai Avenue, Bengbu, Anhui, 233030, China.
Li ShuSchool of Public Health, Bengbu Medical University, No. 2600 Donghai Avenue, Bengbu, Anhui, 233030, China.
Fuyong HuSchool of Public Health, Bengbu Medical University, No. 2600 Donghai Avenue, Bengbu, Anhui, 233030, China.
Jing MiSchool of Public Health, Bengbu Medical University, No. 2600 Donghai Avenue, Bengbu, Anhui, 233030, China. mijing@bbmc.edu.cn.

Funding

Key Projects of Humanities and Social Sciences Research of Anhui Provincial Department of Education no. 2022AH051402Natural Science Key Project of the Anhui Provincial Education Department no. 2023AH051915Natural Science Key Project of the Anhui Provincial Education Department no. KJ2018A1012
6 · The paper itself

Abstract

backgroundDue to the ageing population and evolving lifestyles occurring in China, middle-aged and elderly populations have become high-risk groups for cardiovascular disease (CVD). The aim of this study was to analyse the incidence characteristics of CVD in these populations and develop a prediction model by using data from the China Health and Retirement Longitudinal Study (CHARLS).

methodsWe used follow-up data from the CHARLS to analyse CVD incidence in the Chinese middle-aged and elderly population over a time span of 9 years. Five machine learning (ML) algorithms were employed for risk prediction. Data preprocessing included missing value imputation via random forest. Feature selection was performed using the Least Absolute Shrinkage and Selection Operator (Lasso CV) method with cross-validation prior to model training. The application of the synthetic minority over-sampling technique (SMOTE) to address class imbalance. Model performance was evaluated via analyses including the area under the ROC curve (AUC), precision, recall, F1 score, and SHAP plots for interpretability.

resultsIn accordance with the exclusion criteria, 12,580, 12,061, 11,545, and 11,619 participants were enrolled in four follow-up rounds. The cumulative incidence (CI) of CVD at 2, 4, 7, and 9 years was 2.846%, 8.971%, 17.869% and 20.518%,, respectively. Significant differences in CVD incidence were observed across gender, age, ethnicity, and region, with higher rates observed in females and in the northeast region. Ultimately, 8,080 participants and 24 features were analysed for CVD risk prediction. Five ML models were built based on these features. Although the LGB model achieves an AUC of 0.818, indicating strong overall performance, its F1 score and recall rate are relatively low, at 0.509 and 43.1%, respectively. Shapley additive explanations (SHAP) analyses revealed the importance of key features, such as night sleep duration, TG levels, and waist circumference, in predicting outcomes, and highlighted the nonlinear relationships between these features and CVD risk.

conclusionsGender, age, ethnicity, and region are significant factors influencing CVD incidence. Although the LGB model demonstrates good overall performance, its low F1 score and recall rate reveal limitations in identifying high-risk cardiovascular disease patients.

Indexed as

Cardiovascular DiseasesMachine LearningAgedChinaFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedRisk AssessmentCardiovascular diseaseMachine learningMiddle-aged and elderly individualsMorbidity characteristicsPredictive modelling

Identifiers

PMID39920658
PMCPMC11806717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.